[CNBC Television] GAMCO CEO Mario Gabelli on how he’s assessing the micro and macro landscape
🎯 Загружено автоматически через бота:
🚫 Оригинал видео:
📺 Данное видео принадлежит каналу «CNBC Television» (@CNBCtelevision). Оно представлено в нашем сообществе исключительно в информационных, научных, образовательных или культурных целях. Наше сообщество не утверждает никаких прав на данное видео. Пожалуйста, поддержите автора, посетив его оригинальный канал.
✉️ Если у вас есть претензии к авторским правам на данное видео, пожалуйста, свяжитесь с нами по почте support@, и мы немедленно удалим его.
📃 Оригинальное описание:
Mario Gabelli, chairman and CEO of GAMCO Investors joins CNBC’s “Squawk Box“ to discuss the possibilities of the election results and his outlook for the U.S. economy. “All of your individuals that are talking about the election have compounded and accumulated knowledge because they’ve looked at past elections. From my point of view, I take that same telescope, same microscope and look at individual companies,“ Gabelli told CNBC. For access to live and exclusive video from CNBC subscribe to CNBC PRO:
» Subscribe to CNBC TV:
» Subscribe to CNBC:
» Subscribe to CNBC Classic:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30:
Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Instagram:
#CNBC
#CNBCTV
1 view
12
4
1 month ago 00:03:30 1
[CNBC Television] Two experts discuss what happens to inflation in 2023
1 month ago 00:01:55 1
[CNBC Television] Coronavirus: Here’s an inside look at General Motors’ face mask plant
1 month ago 00:07:10 1
[CNBC Television] GSK CEO: Pfizer venture creates value for both our consumer and pharma businesses